Literature DB >> 17249519

Pathophysiology of antihypertensive therapy with diuretics.

Michio Fukuda1, Genjiro Kimura.   

Abstract

Recent progress in antihypertensive therapy has widened the selection of drugs, and large clinical trials have attracted attention to newer classes of antihypertensives. Consequently, the use of diuretics as antihypertensive agents has been relatively reduced, particularly since the newer drugs are associated with fewer adverse metabolic reactions. However, diuretics have a specific activity of removing sodium from the body fluid, thereby rendering the blood pressure insensitive to sodium intake, relieving the overload to systemic circulation, and normalizing the circadian rhythm of blood pressure from a non-dipper to a dipper pattern. At low doses, diuretics are known to be as effective as all other antihypertensive agents for reducing nearly all types of cardiovascular events. In this brief review, the indication for thiazide diuretics will be discussed based on the pathophysiology of hypertension and antihypertensive therapy with diuretics mainly from the point of view of sodium metabolism. Low-dose diuretics will continue to be an important agent in the treatment of hypertension, mostly in combination with vasodilators such as modulators of the reninangiotensin system and calcium channel blockers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17249519     DOI: 10.1291/hypres.29.645

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

1.  Epoxy Fatty Acids: From Salt Regulation to Kidney and Cardiovascular Therapeutics: 2019 Lewis K. Dahl Memorial Lecture.

Authors:  John D Imig; Wojciech K Jankiewicz; Abdul H Khan
Journal:  Hypertension       Date:  2020-06-01       Impact factor: 10.190

2.  Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis.

Authors:  Satoru Kuriyama; Yasushi Otsuka; Hiroyuki Ueda; Naoki Sugano; Takeo Yoshizawa; Taku Yamada; Tatsuo Hosoya
Journal:  Clin Exp Nephrol       Date:  2010-10-20       Impact factor: 2.801

Review 3.  New Strategies for Volume Control in Patients with Diabetes Mellitus, a Narrative Review.

Authors:  Alexandre O Gérard; Audrey Laurain; Antoine Sicard; Diane Merino; Atul Pathak; Milou-Daniel Drici; Guillaume Favre; Vincent L M Esnault
Journal:  Pharmaceutics       Date:  2022-07-28       Impact factor: 6.525

Review 4.  How Do Antihypertensive Drugs Work? Insights from Studies of the Renal Regulation of Arterial Blood Pressure.

Authors:  Holly Digne-Malcolm; Matthew C Frise; Keith L Dorrington
Journal:  Front Physiol       Date:  2016-07-29       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.